These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15963205)

  • 1. Anticardiolipin antibody and Taiwanese chronic haemodialysis patients with recurrent vascular access thrombosis.
    Chuang FR; Chang HW; Lin CL; Wang IK; Chang HY; Wang PH; Yang CC; Chen TC; Wu CS; Lee CH
    Int J Clin Pract; 2005 Jul; 59(7):785-90. PubMed ID: 15963205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective study.
    Lee CH; Wang IK; Chen TC; Chang HW; Yang CC; Chien YS; Wu CS; Chiou TT; Wu MS; Wang PH; Chuang FR
    Int J Clin Pract; 2006 Dec; 60(12):1591-5. PubMed ID: 16704678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients.
    Chuang FR; Chen TC; Yang CC; Cheng YF; Hsu KT; Lee CH; Lin CL; Wang IK; Chang HW; Wang PH
    Ren Fail; 2005; 27(1):25-30. PubMed ID: 15717631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM anticardiolipin antibodies are associated with stenosis of vascular access in hemodialysis patients but do not predict thrombosis.
    Adler S; Szczech L; Qureshi A; Bollu R; Thomas-John R
    Clin Nephrol; 2001 Dec; 56(6):428-34. PubMed ID: 11770794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinaemia and vascular access thrombosis among chronic hemodialysis patients in Taiwan: a retrospective study.
    Chen TC; Wang IK; Lee CH; Chang HW; Chiou TT; Lee CT; Fang JT; Wu MS; Hsu KT; Yang CC; Wang PH; Chuang FR
    Int J Clin Pract; 2006 Dec; 60(12):1596-9. PubMed ID: 16704682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective study.
    Bowden RG; Wyatt FB; Wilson R
    J Nephrol; 2002; 15(6):666-70. PubMed ID: 12495281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticardiolipin antibodies in hemodialysis patients with hepatitis C and their role in fistula failure.
    Ozmen S; Danis R; Akin D; Batun S
    Clin Nephrol; 2009 Sep; 72(3):193-8. PubMed ID: 19761724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between pulse pressure and vascular access thrombosis in chronic hemodialysis patients.
    Chou CY; Liu JH; Kuo HL; Liu YL; Lin HH; Yang YF; Wang SM; Huang CC
    Hypertens Res; 2009 Aug; 32(8):712-5. PubMed ID: 19590503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies in children on chronic haemodialysis.
    Sallam S; Wafa E; el-Gayar A; Sobh M; Salama O
    Nephrol Dial Transplant; 1994; 9(9):1292-4. PubMed ID: 7816292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus (HEV) infection in haemodialysis patients. The Multicentre Haemodialysis Cohort Study on Viral Hepatitis.
    Psichogiou M; Vaindirli E; Tzala E; Voudiclari S; Boletis J; Vosnidis G; Moutafis S; Skoutelis G; Hadjiconstantinou V; Troonen H; Hatzakis A
    Nephrol Dial Transplant; 1996 Jun; 11(6):1093-5. PubMed ID: 8671974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-year oral alpha-tocopherol administration on anticardiolipin antibodies in hemodialysis patients.
    Antoniadi G; Eleftheriadis T; Liakopoulos V; Kakasi E; Vayonas G; Kortsaris A; Vargemezis V
    Ren Fail; 2005; 27(2):193-8. PubMed ID: 15807185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
    González-Michaca L; Mercado A; Gamba G
    Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of vascular access thrombosis among patients on the cadaveric renal transplantation waiting list.
    Akman B; Afsar B; Ataç FB; Ibis A; Arat Z; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Mar; 38(2):413-5. PubMed ID: 16549134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large prospective survey of anti-cardiolipin antibodies in chronic hemodialysis patients.
    Valeri A; Joseph R; Radhakrishnan J
    Clin Nephrol; 1999 Feb; 51(2):116-21. PubMed ID: 10069647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibody isotype profile in lupus nephritis--a cross sectional survey.
    Azizah MR; Loo CS; Zulkifli MN; Shahnaz M; Zaki M; Nasuruddin BA
    Med J Malaysia; 1998 Sep; 53(3):257-62. PubMed ID: 10968163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic events.
    George J; Aron A; Levy Y; Gilburd B; Ben-David A; Renaudineau Y; Zonana-Nachach A; Youinou P; Harats D; Shoenfeld Y
    Hum Antibodies; 1999; 9(2):125-31. PubMed ID: 10405833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of anticardiolipin antibodies in chronic hepatitis B infection together with total anti-delta positivity].
    Meşe S; Ozekinci T; Atmaca S; Arikan E; Akin D
    Mikrobiyol Bul; 2008 Jul; 42(3):483-7. PubMed ID: 18822893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis.
    Prakash R; Miller CC; Suki WN
    Am J Kidney Dis; 1995 Aug; 26(2):347-52. PubMed ID: 7645540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in thai patients.
    Atchaneeyasakul LO; Trinavarat A; Bumrungsuk P; Wongsawad W
    Jpn J Ophthalmol; 2005; 49(3):211-5. PubMed ID: 15944825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.